Results 171 to 180 of about 46,119 (273)

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma. [PDF]

Cell Death Dis
Costa C, Indovina P, Mattioli E, Forte IM, Iannuzzi CA, Luzzi L, Bellan C, De Summa S, Bucci E, Di Marzo D, De Feo M, Mutti L, Pentimalli F, Giordano A.   +13 more
europepmc   +1 more source

Pharmacogenetics of antidepressant response: a focused review on CYP2C19, CYP2D6, SLC6A4, and HTR2A polymorphisms. [PDF]

Front Pharmacol
Blambila L, Sabei P, Raulino VG, Herkenhoff ME.   +3 more
europepmc   +1 more source

Pharmacogenetics and laboratory medicine: from individual genes towards integral genetic testing. [PDF]

Adv Lab Med
Serra MB, Isidoro-García M.
europepmc   +1 more source

A randomized trial to evaluate attitudes regarding pharmacogenomics among pregnant and pediatric populations: design and baseline characteristics. [PDF]

Pharmacogenomics J
Sundermann AC, Marryshow Batson SE, Jasper EA, Jones SH, Fountain DF, Liu M, Sunthankar SD, Velez Edwards DR.   +7 more
europepmc   +1 more source

The Role of Pharmacogenetics in the Effectiveness of Rheumatoid Arthritis Treatment with Leflunomide. [PDF]

Genes (Basel)
Plewa P, Jędrasiak A, Jerzyńska O, Dach A, Domańska M, Pawlik A.   +5 more
europepmc   +1 more source

An Update to the Clinical Pharmacogenetics Implementation Consortium (CPIC) SLCO1B1 Allele Functionality Table Leveraging Evidence from Participants of Predominantly Sub-Saharan African Ancestry. [PDF]

Clin Pharmacol Ther
Oni-Orisan A, Yee SW, Haldar T, Whirl-Carrillo M, Caudle K, Voora D, Kim RB.   +6 more
europepmc   +1 more source

Molecular Oncodiagnostics in Precision Oncology: Integrating Tumor Transcriptomics, Patient Pharmacogenetics, and Ex Vivo Chemoresistance Testing to Improve Individual Chemotherapy Response. [PDF]

J Pers Med
Rusciano D.
europepmc   +1 more source

Corrigendum to "Pharmacogenetics association with long-term clinical evolution in a kidney transplant patients cohort" [Curr. Res. Pharmacol. Drug Discov. 9 (2025) 100230]. [PDF]

Curr Res Pharmacol Drug Discov
Sendra L, Olivera-Pasquini GG, Zucchet EG, Genvigir FDV, Beneyto MI, Hernández-Jaras J, Herrero MJ, Aliño SF.   +7 more
europepmc   +1 more source

Pharmacogenetic biomarkers for predicting therapeutic response to JAK inhibitors in rheumatoid arthritis. [PDF]

Adv Lab Med
Plasencia-Rodríguez C, Novella-Navarro M, Valdivieso Shephard JL, Martínez-Feito A, Reche-Yebra K, Juárez-García M, Villalba-Yllán A, Rubio-Lepe TS, Arias P, Collada Sánchez VL, Martin-López S, Losantos-García I, Borobia AM, Rosas-Alonso R.   +13 more
europepmc   +1 more source

Genetic biomarkers associated with risk and therapeutic response in erectile dysfunction: a systematic review. [PDF]

Front Pharmacol
Ferezin LP, Kayzuka C, Paiva de Alcântara E Silva M, Tavares Peixeiro CN, Rondon-Pereira VC, Tanus-Santos JE, Lacchini R.   +6 more
europepmc   +1 more source